Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sales drop

This article was originally published in The Tan Sheet

Executive Summary

Mannatech reports a loss of $3.6 million for its fiscal 2007 fourth quarter due to declining sales and $4.7 million in litigation expenses. In August, co-founder and CEO Sam Caster resigned amid Mannatech's defense of the class action (1"The Tan Sheet" Aug. 27, 2007, In Brief). Sales for the October-December period fell 6.5 percent to $99.9 million from $106.8 million. The firm says North American sales dropped 20 percent, but international sales rose 27 percent. In a March 14 release, President and CEO Terry Persinger said the firm will focus on global business development and cost management and expects better results in the later part of the year...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS101488

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel